Schedule of Investments
ARK Innovation ETF
April 30, 2022 (Unaudited)
Investments | Shares | Value | ||||||
COMMON STOCKS–100.0% | ||||||||
Automobiles - 9.6% | ||||||||
Tesla, Inc.* | 973,892 | $ | 848,026,198 | |||||
Biotechnology - 19.3% | ||||||||
Beam Therapeutics, Inc.*† | 6,315,139 | 237,007,167 | ||||||
CRISPR Therapeutics AG (Switzerland)*† | 6,390,895 | 317,116,210 | ||||||
Exact Sciences Corp.* | 8,731,617 | 480,675,516 | ||||||
Fate Therapeutics, Inc.*† | 6,469,935 | 184,781,344 | ||||||
Intellia Therapeutics, Inc.*† | 6,078,674 | 298,037,386 | ||||||
Twist Bioscience Corp.*† | 3,155,959 | 91,017,857 | ||||||
Veracyte, Inc.*† | 5,137,932 | 105,173,468 | ||||||
Total Biotechnology | 1,713,808,948 | |||||||
Capital Markets - 8.0% | ||||||||
Coinbase Global, Inc., Class A* | 4,548,802 | 512,695,473 | ||||||
Robinhood Markets, Inc., Class A* | 19,921,977 | 195,334,985 | ||||||
Total Capital Markets | 708,030,458 | |||||||
Chemcials - 1.5% | ||||||||
Ginkgo Bioworks Holdings, Inc.* | 45,101,551 | 130,794,498 | ||||||
Diversified Consumer Services - 0.7% | ||||||||
2U, Inc.*† | 5,944,101 | 59,322,128 | ||||||
Entertainment - 13.2% | ||||||||
ROBLOX Corp., Class A* | 4,939,362 | 151,391,445 | ||||||
Roku, Inc.*† | 6,979,464 | 648,392,206 | ||||||
Sea Ltd. (Taiwan)*(a) | 1,174,680 | 97,216,517 | ||||||
Spotify Technology SA* | 2,708,427 | 275,311,605 | ||||||
Total Entertainment | 1,172,311,773 | |||||||
Health Care Equipment & Supplies - 0.6% | ||||||||
Cerus Corp.*† | 10,788,344 | 49,842,149 | ||||||
Health Care Providers & Services - 3.0% | ||||||||
Invitae Corp.*† | 18,041,062 | 95,798,039 | ||||||
Signify Health, Inc., Class A*† | 12,100,604 | 166,988,335 | ||||||
Total Health Care Providers & Services | 262,786,374 | |||||||
Health Care Technology - 4.5% | ||||||||
Teladoc Health, Inc.*† | 11,709,937 | 395,327,473 | ||||||
Hotels Restaurants & Leisure - 2.4% | ||||||||
DraftKings, Inc., Class A* | 15,201,148 | 207,951,705 | ||||||
IT Services - 12.9% | ||||||||
Block, Inc.* | 5,246,043 | 522,191,120 | ||||||
Shopify, Inc., Class A (Canada)* | 597,308 | 254,943,000 | ||||||
Twilio, Inc., Class A* | 3,216,290 | 359,645,548 | ||||||
Total IT Services | 1,136,779,668 | |||||||
Life Sciences Tools & Services - 2.8% | ||||||||
10X Genomics, Inc., Class A* | 2,524,169 | 120,554,312 | ||||||
Berkeley Lights, Inc.*† | 5,049,983 | 25,123,666 | ||||||
Compugen Ltd. (Israel)*† | 6,183,127 | 14,715,842 | ||||||
Pacific Biosciences of California, Inc.*† | 13,026,771 | 82,589,728 | ||||||
Total Life Sciences Tools & Services | 242,983,548 | |||||||
Road & Rail - 1.0% | ||||||||
TuSimple Holdings, Inc., Class A* | 8,682,060 | 90,032,962 | ||||||
Software - 19.4% | ||||||||
Materialise NV (Belgium)*†(a) | 4,104,425 | 64,029,030 | ||||||
PagerDuty, Inc.*† | 7,533,409 | 215,229,495 | ||||||
UiPath, Inc., Class A* | 19,621,711 | 349,855,107 | ||||||
Unity Software, Inc.* | 6,064,009 | 402,710,838 | ||||||
Zoom Video Communications, Inc., Class A* | 6,954,157 | 692,425,412 | ||||||
Total Software | 1,724,249,882 | |||||||
Technology Hardware, Storage & Peripherals - 1.1% | ||||||||
Stratasys Ltd.*† | 5,103,980 | 98,966,172 | ||||||
Total Common Stocks (Cost $21,163,306,289) | 8,841,213,936 | |||||||
MONEY MARKET FUND–0.1% | ||||||||
Dreyfus Government Cash Management Fund, Institutional Shares, 0.24% (b) (Cost $6,941,911) | 6,941,911 | 6,941,911 | ||||||
Total Investments–100.1% (Cost $21,170,248,200) | 8,848,155,847 | |||||||
Liabilities in Excess of Other Assets–(0.1)% | (7,739,733 | ) | ||||||
Net Assets–100.0% | $ | 8,840,416,114 |
Schedule of Investments (continued)
ARK Innovation ETF
April 30, 2022 (Unaudited)
Affiliated Issuer Transactions
A summary of the Fund’s period to date transactions with companies which are or were affiliated issuers during the period are as follows:
Value ($) at 7/31/2021 | Purchases Cost ($) | Sales Proceeds ($) | Net Realized Gain/(Loss) ($) | Net Change in Unrealized Appreciation (Depreciation) ($) | Dividend Income ($) | Capital Gain Distributions ($) | Number of Shares at 4/30/2022 | Value ($) at 4/30/2022 | ||||||||||||||||||||||||||
Common Stocks — 35.6% | ||||||||||||||||||||||||||||||||||
Biotechnology — 13.9% | ||||||||||||||||||||||||||||||||||
Beam Therapeutics, Inc. | ||||||||||||||||||||||||||||||||||
429,666,220 | 551,463,023 | (417,927,915 | ) | 18,992,165 | (345,186,326 | ) | – | – | 6,315,139 | 237,007,167 | ||||||||||||||||||||||||
CRISPR Therapeutics AG | ||||||||||||||||||||||||||||||||||
590,141,202 | 579,148,730 | (451,325,846 | ) | 58,099,332 | (458,947,208 | ) | – | – | 6,390,895 | 317,116,210 | ||||||||||||||||||||||||
Editas Medicine, Inc. | ||||||||||||||||||||||||||||||||||
179,157,870 | 60,451,666 | (169,471,797 | ) | (22,174,212 | ) | (47,963,527 | ) | – | – | – | – | |||||||||||||||||||||||
Fate Therapeutics, Inc. | ||||||||||||||||||||||||||||||||||
368,294,731 | 419,605,819 | (289,719,821 | ) | (5,036,964 | ) | (308,362,421 | ) | – | – | 6,469,935 | 184,781,344 | |||||||||||||||||||||||
Intellia Therapeutics, Inc. | ||||||||||||||||||||||||||||||||||
588,966,306 | 717,238,427 | (528,448,987 | ) | 349,961,841 | (829,680,201 | ) | – | – | 6,078,674 | 298,037,386 | ||||||||||||||||||||||||
Iovance Biotherapeutics, Inc. | ||||||||||||||||||||||||||||||||||
189,057,134 | 36,882,663 | (203,371,000 | ) | (164,614,792 | ) | 142,045,995 | – | – | – | – | ||||||||||||||||||||||||
Twist Bioscience Corp. | ||||||||||||||||||||||||||||||||||
226,589,192 | 194,497,466 | (136,920,768 | ) | 13,088,963 | (206,236,996 | ) | – | – | 3,155,959 | 91,017,857 | ||||||||||||||||||||||||
Veracyte, Inc. | ||||||||||||||||||||||||||||||||||
146,417,966 | 218,991,016 | (149,394,045 | ) | 25,796,303 | (136,637,772 | ) | – | – | 5,137,932 | 105,173,468 | ||||||||||||||||||||||||
Diversified Consumer Services — 0.7% | ||||||||||||||||||||||||||||||||||
2U, Inc. | ||||||||||||||||||||||||||||||||||
223,797,134 | 120,166,213 | (107,632,384 | ) | 14,558,329 | (191,567,164 | ) | – | – | 5,944,101 | 59,322,128 | ||||||||||||||||||||||||
Diversified Telecommunication — 0.0% | ||||||||||||||||||||||||||||||||||
Iridium Communications, Inc. | ||||||||||||||||||||||||||||||||||
351,317,071 | 128,645,635 | (427,230,884 | ) | (44,184,594 | ) | (8,547,228 | ) | – | – | – | – | |||||||||||||||||||||||
Entertainment — 7.3% | ||||||||||||||||||||||||||||||||||
Roku, Inc. | ||||||||||||||||||||||||||||||||||
1,277,506,103 | 1,645,031,201 | (896,659,687 | ) | 180,065,762 | (1,557,551,173 | ) | – | – | 6,979,464 | 648,392,206 | ||||||||||||||||||||||||
Health Care Equipment & Supplies — 0.6% | ||||||||||||||||||||||||||||||||||
Cerus Corp. | ||||||||||||||||||||||||||||||||||
61,502,127 | 50,703,637 | (60,901,307 | ) | 2,402,549 | (3,864,857 | ) | – | – | 10,788,344 | 49,842,149 | ||||||||||||||||||||||||
Health Care Providers & Services — 3.0% | ||||||||||||||||||||||||||||||||||
Invitae Corp. | ||||||||||||||||||||||||||||||||||
331,826,516 | 383,191,208 | (240,281,185 | ) | 36,886,080 | (415,824,580 | ) | – | – | 18,041,062 | 95,798,039 | ||||||||||||||||||||||||
Signify Health, Inc. | ||||||||||||||||||||||||||||||||||
– | 415,199,017 | (157,474,973 | ) | 5,485,787 | (96,221,496 | ) | – | – | 12,100,604 | 166,988,335 | ||||||||||||||||||||||||
Health Care Technology — 4.5% | ||||||||||||||||||||||||||||||||||
Teladoc Health, Inc. | ||||||||||||||||||||||||||||||||||
1,309,104,544 | 1,218,920,818 | (944,340,754 | ) | (5,097,628 | ) | (1,183,259,507 | ) | – | – | 11,709,937 | 395,327,473 | |||||||||||||||||||||||
Life Sciences Tools & Services — 1.4% | ||||||||||||||||||||||||||||||||||
Berkeley Lights, Inc. | ||||||||||||||||||||||||||||||||||
158,277,143 | 106,909,313 | (67,565,913 | ) | (1,841,946 | ) | (170,654,931 | ) | – | – | 5,049,983 | 25,123,666 | |||||||||||||||||||||||
Compugen Ltd. | ||||||||||||||||||||||||||||||||||
43,591,664 | 19,613,881 | (24,163,444 | ) | 1,992,164 | (26,318,423 | ) | – | – | 6,183,127 | 14,715,842 | ||||||||||||||||||||||||
Pacific Biosciences of California, Inc. | ||||||||||||||||||||||||||||||||||
246,859,499 | 291,826,907 | (177,021,549 | ) | 61,942,173 | (341,017,302 | ) | – | – | 13,026,771 | 82,589,728 | ||||||||||||||||||||||||
Machinery — 0.0% | ||||||||||||||||||||||||||||||||||
Proto Labs, Inc. | ||||||||||||||||||||||||||||||||||
155,624,215 | 12,316,665 | (150,882,022 | ) | (120,312,087 | ) | 103,253,229 | – | – | – | – | ||||||||||||||||||||||||
Software — 3.1% | ||||||||||||||||||||||||||||||||||
Materialise NV | ||||||||||||||||||||||||||||||||||
80,375,733 | 86,566,683 | (77,200,681 | ) | 2,025,572 | (27,738,277 | ) | – | – | 4,104,425 | 64,029,030 | ||||||||||||||||||||||||
PagerDuty, Inc. | ||||||||||||||||||||||||||||||||||
224,620,189 | 322,217,883 | (248,306,084 | ) | 49,700,074 | (133,002,567 | ) | – | – | 7,533,409 | 215,229,495 | ||||||||||||||||||||||||
Technology Hardware, Storage & Peripherals — 1.1% | ||||||||||||||||||||||||||||||||||
Stratasys Ltd. | ||||||||||||||||||||||||||||||||||
81,818,214 | 128,759,896 | (106,279,227 | ) | 14,177,267 | (19,509,978 | ) | – | – | 5,103,980 | 98,966,172 | ||||||||||||||||||||||||
$ | 7,264,510,773 | $ | 7,708,347,767 | $ | (6,032,520,273 | ) | $ | 471,912,138 | $ | (6,262,792,710 | ) | $ | – | $ | – | 140,113,741 | $ | 3,149,457,695 |
† | Affiliated security |
* | Non-income producing security |
(a) | American Depositary Receipt |
(b) | Rate shown represents annualized 7-day yield as of April 30, 2022. |
Schedule of Investments (continued)
ARK Innovation ETF
April 30, 2022 (Unaudited)
Fair Value Measurement
The Fund discloses the fair value of its investments in a hierarchy that distinguishes between: (i) market participant assumptions developed based on market data obtained from sources independent of the Fund (observable inputs) and (ii) the Fund’s own assumptions about market participant assumptions developed based on the best information available under the circumstances (unobservable inputs). The three levels defined by the hierarchy are as follows:
• Level 1 — Quoted prices in active markets for identical assets.
• Level 2 — Other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.).
• Level 3 — Significant unobservable inputs (including each Fund’s own assumptions in determining the fair value of investments).
The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.
The following is a summary of the valuations as of April 30, 2022, based upon the three levels defined above:
ARK Innovation ETF | Level 1 | Level 2 | Level 3 | Total | ||||||||||||
Assets | ||||||||||||||||
Common Stocks‡ | $ | 8,841,213,936 | $ | – | $ | – | $ | 8,841,213,936 | ||||||||
Money Market Fund | 6,941,911 | – | – | 6,941,911 | ||||||||||||
Total | $ | 8,848,155,847 | $ | – | $ | – | $ | 8,848,155,847 |
‡ | Please refer to the Schedule of Investments to view securities segregated by industry type. |